Andrea Doraine Emard, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-5000 |
News Archive
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Two University of South Carolina alumni with a desire to transform pharmacy education and practice are making a $30 million gift to the university's South Carolina College of Pharmacy, the second-largest in the university's history.
The New York Times reports that last week's action at the Supreme Court gave the public an in-depth view of the insitution and the justices. Meanwhile, the Associated Press reports that, in a recent speech, Justice Sonia Sotomayor didn't give any hints about what the high court will do on the health law question.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.
› Verified 9 days ago